Medical Biochemistry

Doç. Dr. İnanç Karakoyun

Doctor and researcher İzmir Şehir Hastanesi İzmir
COVID-19Breast NeoplasmsObesity
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • COVID-19 3 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Breast Neoplasms 2 publications
  • Obesity 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyMedical Biochemistrysaglik.gov.trFrom source
  • Institutionİzmir Şehir Hastanesisaglik.gov.trFrom source
  • Area of workCOVID-19Extracted from 3 publications · Model version —From source
  • Publications53 publicationsOpenAlex, ORCIDFrom source
  • ORCID0000-0002-7057-171XORCIDFrom source
  • Last synchronised5 November 2026 09:07https://izmirsehir.saglik.gov.tr/TR-1046862/doktorlarimiz.html#inanc-karakoyunsaglik.gov.tr

Scientific work

Publications on COVID-19

53 publications

  1. Rapid identification of severe hypoglycemia and hyperglycemia in hospitalized patients using laboratory-integrated machine learning

    Internal and Emergency Medicine, 2026

    DOI 10.1007/s11739-026-04557-x PMID 42961620 Source: OpenAlex

  2. Reply to: Letter to the editor: Exercise, biomarkers, and cancer: considering the nuances in study design and interpretation

    Supportive Care in Cancer, 2026

    DOI 10.1007/s00520-026-10617-x PMID 41902994 Source: ORCID

  3. Can Previous D-Dimer Levels Predict Future Elevations in Emergency Department Patients?

    Anatolian Journal of Emergency Medicine, 2025

    DOI 10.54996/anatolianjem.1655313 Open-access full textSource: ORCID

  4. Clinicians’ perspectives and practices on critical outcomes and their expectations from the laboratory

    Turkish Journal of Biochemistry, 2025

    DOI 10.1515/tjb-2025-0024 Open-access full textSource: ORCID

  5. Myotonic dystrophy type 1 and oxidative imbalance: evaluation of ischemia-modified albumin and oxidant stress

    Turkish Journal of Biochemistry, 2025

    DOI 10.1515/tjb-2024-0219 Open-access full textSource: ORCID

  6. Leucine-Rich Alpha-2 Glycoprotein 1 as a Biomarker for Evaluation of Inflammatory Bowel Disease Activity in Children †

    Journal of Clinical Medicine, 2025

    DOI 10.3390/jcm14082803 PMID 40283634 3 citations (Europe PMC) Open-access full textSource: ORCID

  7. Certolizumab enhances spinal cord injury recovery in rats through inhibition of the TNF-α signaling pathway and neuronal apoptosis

    Inflammopharmacology, 2025

    DOI 10.1007/s10787-025-01674-5 PMID 40009347 7 citations (OpenAlex) Open-access full textSource: OpenAlex

  8. Evaluation of reference intervals for immunoglobulins in children using indirect methods

    Am J Clin Pathol, 2025

    DOI 10.1093/ajcp/aqaf111 PMID 41351888 Source: ORCID

  9. The effect of supervised aerobic exercise on adipokine and myokine biomarkers in patients with cancer during systemic chemotherapy: a single-blinded prospective controlled trial

    Supportive Care in Cancer, 2025

    DOI 10.1007/s00520-025-09788-w PMID 40751845 7 citations (Europe PMC) Source: ORCID

  10. Evaluation of neurofilament light chain levels in multiple sclerosis during acute attack periods

    Cukurova Medical Journal, 2024

    DOI 10.17826/cumj.1463251 Open-access full textSource: ORCID

View all 53 publications